Sustained remission of type 2 diabetes in rodents by centrally administered fibroblast growth factor 4
- 10 May 2023
- journal article
- research article
- Published by Elsevier in Cell Metabolism
- Vol. 35 (6) , 1022-1037.e6
Abstract
No abstract availableKeywords
Funding Information
- National Key Research and Development Program of China (2019YFA0801900)
- National Natural Science Foundation of China (31900707, 32122039, 81874323, 91857104, 92057122)
This publication has 66 references indexed in Scilit:
- Intranasal Treatment of Central Nervous System Dysfunction in HumansPharmaceutical Research, 2012
- Plasticity in Interactions of Fibroblast Growth Factor 1 (FGF1) N Terminus with FGF Receptors Underlies Promiscuity of FGF1Journal of Biological Chemistry, 2012
- Leptin Action on GABAergic Neurons Prevents Obesity and Reduces Inhibitory Tone to POMC NeuronsNeuron, 2011
- ATP‐mediated glucosensing by hypothalamic tanycytesThe Journal of Physiology, 2011
- Fibroblast growth factors: from molecular evolution to roles in development, metabolism and diseaseThe Journal of Biochemistry, 2010
- AMP-activated protein kinase and nitric oxide regulate the glucose sensitivity of ventromedial hypothalamic glucose-inhibited neuronsAmerican Journal of Physiology-Cell Physiology, 2009
- Homodimerization Controls the Fibroblast Growth Factor 9 Subfamily's Receptor Binding and Heparan Sulfate-Dependent Diffusion in the Extracellular MatrixMolecular and Cellular Biology, 2009
- Contribution of the T1r3 Taste Receptor to the Response Properties of Central Gustatory NeuronsJournal of Neurophysiology, 2009
- The FGF family: biology, pathophysiology and therapyNature Reviews Drug Discovery, 2009
- FGF-21 as a novel metabolic regulatorJournal of Clinical Investigation, 2005